Literature DB >> 20375169

Persistence of viremia and production of neutralizing antibodies differentially regulated by polymorphic APOBEC3 and BAFF-R loci in friend virus-infected mice.

Sachiyo Tsuji-Kawahara1, Tomomi Chikaishi, Eri Takeda, Maiko Kato, Saori Kinoshita, Eiji Kajiwara, Shiki Takamura, Masaaki Miyazawa.   

Abstract

Several host genes control retroviral replication and pathogenesis through the regulation of immune responses to viral antigens. The Rfv3 gene influences the persistence of viremia and production of virus-neutralizing antibodies in mice infected with Friend mouse retrovirus complex (FV). This locus has been mapped within a narrow segment of mouse chromosome 15 harboring the APOBEC3 and BAFF-R loci, both of which show functional polymorphisms among different strains of mice. The exon 5-lacking product of the APOBEC3 allele expressed in FV-resistant C57BL/6 (B6) mice directly restricts viral replication, and mice lacking the B6-derived APOBEC3 exhibit exaggerated pathology and reduced production of neutralizing antibodies. However, the mechanisms by which the polymorphisms at the APOBEC3 locus affect the production of neutralizing antibodies remain unclear. Here we show that the APOBEC3 genotypes do not directly affect the B-cell repertoire, and mice lacking B6-derived APOBEC3 still produce FV-neutralizing antibodies in the presence of primed T helper cells. Instead, higher viral loads at a very early stage of FV infection caused by either a lack of the B6-derived APOBEC3 or a lack of the wild-type BAFF-R resulted in slower production of neutralizing antibodies. Indeed, B cells were hyperactivated soon after infection in the APOBEC3- or BAFF-R-deficient mice. In contrast to mice deficient in the B6-derived APOBEC3, which cleared viremia by 4 weeks after FV infection, mice lacking the functional BAFF-R allele exhibited sustained viremia, indicating that the polymorphisms at the BAFF-R locus may better explain the Rfv3-defining phenotype of persistent viremia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20375169      PMCID: PMC2876660          DOI: 10.1128/JVI.02516-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Genotypes at chromosome 22q12-13 are associated with HIV-1-exposed but uninfected status in Italians.

Authors:  Yasuyoshi Kanari; Mario Clerici; Hiroyuki Abe; Hiroyuki Kawabata; Daria Trabattoni; Sergio Lo Caputo; Francesco Mazzotta; Hironori Fujisawa; Atsuko Niwa; Chiaki Ishihara; Yumiko A Takei; Masaaki Miyazawa
Journal:  AIDS       Date:  2005-07-01       Impact factor: 4.177

2.  Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection.

Authors:  U Dittmer; D M Brooks; K J Hasenkrug
Journal:  Nat Med       Date:  1999-02       Impact factor: 53.440

3.  Fv2 encodes a truncated form of the Stk receptor tyrosine kinase.

Authors:  D A Persons; R F Paulson; M R Loyd; M T Herley; S M Bodner; A Bernstein; P H Correll; P A Ney
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

4.  Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders.

Authors:  Domenico Rosa; Giulietta Saletti; Ennio De Gregorio; Francesca Zorat; Consuelo Comar; Ugo D'Oro; Sandra Nuti; Michael Houghton; Vincenzo Barnaba; Gabriele Pozzato; Sergio Abrignani
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-09       Impact factor: 11.205

5.  Fine mapping of the friend retrovirus resistance gene, Rfv3, on mouse chromosome 15.

Authors:  H J Super; K J Hasenkrug; S Simmons; D M Brooks; R Konzek; K D Sarge; R I Morimoto; N A Jenkins; D J Gilbert; N G Copeland; W Frankel; B Chesebro
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

6.  Lymphocyte deficiencies increase susceptibility to friend virus-induced erythroleukemia in Fv-2 genetically resistant mice.

Authors:  K J Hasenkrug
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

7.  Mice deficient in APOBEC2 and APOBEC3.

Authors:  Marie C Mikl; Ian N Watt; Mason Lu; Wolf Reik; Sarah L Davies; Michael S Neuberger; Cristina Rada
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

8.  Bcmd governs recruitment of new B cells into the stable peripheral B cell pool in the A/WySnJ mouse.

Authors:  V M Lentz; M P Cancro; F E Nashold; C E Hayes
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

9.  Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions.

Authors:  Kehmia Titanji; Francesca Chiodi; Rino Bellocco; Danika Schepis; Lyda Osorio; Chiara Tassandin; Giuseppe Tambussi; Sven Grutzmeier; Lucia Lopalco; Angelo De Milito
Journal:  AIDS       Date:  2005-11-18       Impact factor: 4.177

10.  Functional B cell abnormalities in HIV type 1 infection: role of CD40L and CD70.

Authors:  K C Wolthers; S A Otto; S M Lens; R A Van Lier; F Miedema; L Meyaard
Journal:  AIDS Res Hum Retroviruses       Date:  1997-08-10       Impact factor: 2.205

View more
  27 in total

1.  Innate immune sensing of retroviral infection via Toll-like receptor 7 occurs upon viral entry.

Authors:  Melissa Kane; Laure K Case; Christine Wang; Leonid Yurkovetskiy; Stanislav Dikiy; Tatyana V Golovkina
Journal:  Immunity       Date:  2011-06-30       Impact factor: 31.745

2.  Immunoglobulin VH gene diversity and somatic hypermutation during SIV infection of rhesus macaques.

Authors:  Kejun Guo; Kalani Halemano; Kimberly Schmitt; Miki Katuwal; Yaqiong Wang; Michael S Harper; Karl J Heilman; Takeo Kuwata; Edward B Stephens; Mario L Santiago
Journal:  Immunogenetics       Date:  2015-05-21       Impact factor: 2.846

3.  Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response.

Authors:  Kalani Halemano; Bradley S Barrett; Karl J Heilman; Thomas E Morrison; Mario L Santiago
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

4.  Natural killer cells recognize friend retrovirus-infected erythroid progenitor cells through NKG2D-RAE-1 interactions In Vivo.

Authors:  Tatsuya Ogawa; Sachiyo Tsuji-Kawahara; Takae Yuasa; Saori Kinoshita; Tomomi Chikaishi; Shiki Takamura; Haruo Matsumura; Tsukasa Seya; Toshihiko Saga; Masaaki Miyazawa
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

5.  Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor.

Authors:  Mario L Santiago; Diana S Smith; Bradley S Barrett; Mauricio Montano; Robert L Benitez; Roberta Pelanda; Kim J Hasenkrug; Warner C Greene
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

6.  Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo.

Authors:  Mario L Santiago; Robert L Benitez; Mauricio Montano; Kim J Hasenkrug; Warner C Greene
Journal:  J Immunol       Date:  2010-06-21       Impact factor: 5.422

7.  Class switch recombination and somatic hypermutation of virus-neutralizing antibodies are not essential for control of friend retrovirus infection.

Authors:  Maiko Kato; Sachiyo Tsuji-Kawahara; Yuri Kawasaki; Saori Kinoshita; Tomomi Chikaishi; Shiki Takamura; Makoto Fujisawa; Akira Kawada; Masaaki Miyazawa
Journal:  J Virol       Date:  2014-11-05       Impact factor: 5.103

8.  Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex.

Authors:  Spyridon Stavrou; Takayuki Nitta; Swathi Kotla; Dat Ha; Kunio Nagashima; Alan R Rein; Hung Fan; Susan R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

Review 9.  Humoral immunity in the Friend retrovirus infection model.

Authors:  Kalani Halemano; Michael S Harper; Kejun Guo; Sam X Li; Karl J Heilman; Bradley S Barrett; Mario L Santiago
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

10.  Differential requirements of cellular and humoral immune responses for Fv2-associated resistance to erythroleukemia and for regulation of retrovirus-induced myeloid leukemia development.

Authors:  Sachiyo Tsuji-Kawahara; Hiroyuki Kawabata; Hideaki Matsukuma; Saori Kinoshita; Tomomi Chikaishi; Mayumi Sakamoto; Yuri Kawasaki; Masaaki Miyazawa
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.